Start Date
December 31, 2014
Primary Completion Date
September 30, 2017
Study Completion Date
April 30, 2018
Sorafenib (Nexavar, BAY43-9006)
The treatment with Sorafenib 200mg tablets should comply with the recommendations written in the local product information. The decision about the duration of treatment is solely at the discretion of the attending physician
Lead Sponsor
Bayer
INDUSTRY